10/13/2014 – Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, ALNY:
1. In previous Williams edge stock meetings it was noted that Alnylam pharmaceuticals could be bought upon any confirmed breakout above $80 for a forecast advance to $87/$89. Partial exits were instructed to be taken at/near $83.50.
2. Today’s (Mon., Oct. 13) session broke out on the upside above $80 and completed the run to the $87/$89 upside target (session high, $87.95, so far).
3. Some remaining position should be held for the possibility of higher prices beyond $89. Will update as the market continues to confirm.
David Williams
CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.